Dela Cruz, Rena .

HRN: 28-56-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2026
AMPICILLIN 1GM (VIAL)
02/21/2026
02/28/2026
IV
2g
Q6hrs
PROM
Remove - Pending Acceptance
02/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2026
02/22/2026
IV
600 Mg
Once
POP
Checking Initial Appropriateness 
02/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/22/2026
02/23/2026
IV
500 Mg
Q8
Sp 1 LTCS
Remove - Pending Acceptance
02/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2026
02/23/2026
IV
900 Mg
Q8 X 3 Doses
Sp 1 LTCS
Remove - Pending Acceptance
02/23/2026
CLINDAMYCIN 300MG (CAP)
02/23/2026
03/01/2026
PO
300 Mg
TID
Sp 1 LTCS
Checking Initial Appropriateness 
02/23/2026
METRONIDAZOLE 500MG (TAB)
02/23/2026
03/01/2026
PO
500 Mg
TID
Sp 1 LTCS
Checking Initial Appropriateness 
02/24/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/24/2026
03/02/2026
IV
900mg
Q8
Sp 1 LTCS, Thickly MSAF
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: